2022年世卫组织垂体瘤分类的临床整合和应用
Sylvia L Asa1, Shereen Ezzat2, Ozgur Mete3
1Department of Pathology, University Hospitals Cleveland, Case Western Reserve University, Cleveland, Ohio, USA.
Neuro-oncology advances
|July 28, 2025
概括
垂体瘤,包括垂体神经内分泌瘤 (PitNETs),已根据细胞系和分子特征进行分类. 提前帮助区分瘤类型和亚型,以改善临床管理.
科学领域:
- 内分泌学 在内分泌学.
- 神经瘤学神经瘤学
- 病理学 病理学 病理学
背景情况:
- 垂体腺是各种瘤的来源,包括神经内分泌,质和发育性瘤.
- 近几十年来,在使用细胞系,分子数据和生物标志物对这些瘤进行分类方面取得了进展.
研究的目的:
- 根据最近的进展,审查垂体瘤的分类.
- 突出临床,放射学和病理学区别以及治疗影响.
主要方法:
- 关于下垂体瘤分类的科学文献的综述.
- 细胞谱系,分子变化和生物标记特征的分析.
- 瘤亚型与临床表现和遗传因素的相关性.
主要成果:
- 垂体瘤包括PitNETs,垂体细胞瘤,下丘脑神经元瘤,脑瘤和垂体母细胞瘤.
- 分类依赖于细胞分化的途径,形态学和独特的遗传变化.
- 综合征性疾病已经确定了一些致病基因,但大多数瘤是零星的.
结论:
- 精确的下垂体瘤分类对于临床区分和治疗策略至关重要.
- 了解结构功能相关性有助于对临床疾病进行分类.
- 需要对遗传倾向和表观遗传因素进行进一步的研究.
相关概念视频
01:17The Pituitary Gland
7.3K
The pituitary is a small endocrine organ in the sphenoid bone under the hypothalamus. Primarily, the pituitary in adults has two distinct anatomical and functional regions— the anterior and posterior lobes. During human fetal development, a third pituitary gland region called the pars intermedia atrophies and disappears. However, some of its cells migrate and exist adjacent to the anterior pituitary in adults.
7.3K
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K